Keywords
Last Name
Institution

Lloyd Mayer

Address5 East 98th Street
11th Floor
New York NY 10029
Phone212-241-0764
Fax212-534-0971

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Song Y, Dunkin D, Dahan S, Iuga A, Ceballos C, Hoffstadter-Thal K, Yang N, Benkov K, Mayer L, Li XM. Anti-inflammatory Effects of the Chinese Herbal Formula FAHF-2 in Experimental and Human IBD. Inflamm Bowel Dis. 2014 Jan; 20(1):144-53.
      View in: PubMed
    2. Shan M, Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K, He B, Cassis L, Bigas A, Cols M, Comerma L, Huang B, Blander JM, Xiong H, Mayer L, Berin C, Augenlicht LH, Velcich A, Cerutti A. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science. 2013 Oct 25; 342(6157):447-53.
      View in: PubMed
    3. Ruane D, Brane L, Reis BS, Cheong C, Poles J, Do Y, Zhu H, Velinzon K, Choi JH, Studt N, Mayer L, Lavelle EC, Steinman RM, Mucida D, Mehandru S. Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract. J Exp Med. 2013 Aug 26; 210(9):1871-88.
      View in: PubMed
    4. Agarwal S, Mayer L. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol. 2013 Sep; 11(9):1050-63.
      View in: PubMed
    5. Mayer L, Pandak WM, Melmed GY, Hanauer SB, Johnson K, Payne D, Faleck H, Hariri RJ, Fischkoff SA. Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study. Inflamm Bowel Dis. 2013 Mar-Apr; 19(4):754-60.
      View in: PubMed
    6. Denmark VK, Mayer L. Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update. Expert Rev Clin Immunol. 2013 Jan; 9(1):77-92.
      View in: PubMed
    7. Berin MC, Mayer L. Can we produce true tolerance in patients with food allergy? J Allergy Clin Immunol. 2013 Jan; 131(1):14-22.
      View in: PubMed
    8. Fleischer DM, Burks AW, Vickery BP, Scurlock AM, Wood RA, Jones SM, Sicherer SH, Liu AH, Stablein D, Henning AK, Mayer L, Lindblad R, Plaut M, Sampson HA. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol. 2013 Jan; 131(1):119-27.e1-7.
      View in: PubMed
    9. Wood RA, Sicherer SH, Vickery BP, Jones SM, Liu AH, Fleischer DM, Henning AK, Mayer L, Burks AW, Grishin A, Stablein D, Sampson HA. The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol. 2013 Mar; 131(3):805-12.
      View in: PubMed
    10. Rabinowitz KM, Wang Y, Chen EY, Hovhannisyan Z, Chiang D, Berin MC, Dahan S, Chaussabel D, Ma'ayan A, Mayer L. Transforming growth factor ß signaling controls activities of human intestinal CD8(+)T suppressor cells. Gastroenterology. 2013 Mar; 144(3):601-612.e1.
      View in: PubMed
    11. Kinnunen T, Chamberlain N, Morbach H, Choi J, Kim S, Craft J, Mayer L, Cancrini C, Passerini L, Bacchetta R, Ochs HD, Torgerson TR, Meffre E. Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. Blood. 2013 Feb 28; 121(9):1595-603.
      View in: PubMed
    12. Rabinowitz K, Mayer L. Working out mechanisms of controlled/physiologic inflammation in the GI tract. Immunol Res. 2012 Dec; 54(1-3):14-24.
      View in: PubMed
    13. Steele L, Mayer L, Berin MC. Mucosal immunology of tolerance and allergy in the gastrointestinal tract. Immunol Res. 2012 Dec; 54(1-3):75-82.
      View in: PubMed
    14. Mayer L, Lira S, Ting A, Cortes P. Introduction to the special issue on Immunology at Mount Sinai. Immunol Res. 2012 Dec; 54(1-3):1-3.
      View in: PubMed
    15. Feldman EJ, Kolitz JE, Trang JM, Liboiron BD, Swenson CE, Chiarella MT, Mayer LD, Louie AC, Lancet JE. Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia. Leuk Res. 2012 Oct; 36(10):1283-9.
      View in: PubMed
    16. Bongers G, Muniz LR, Pacer ME, Iuga AC, Thirunarayanan N, Slinger E, Smit MJ, Reddy EP, Mayer L, Furtado GC, Harpaz N, Lira SA. A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans. Gastroenterology. 2012 Sep; 143(3):730-40.
      View in: PubMed
    17. Mayer L, Kaser A, Blumberg RS. Dead on arrival: understanding the failure of CTLA4-immunoglobulin therapy in inflammatory bowel disease. Gastroenterology. 2012 Jul; 143(1):13-7.
      View in: PubMed
    18. Kenny EE, Pe'er I, Karban A, Ozelius L, Mitchell AA, Ng SM, Erazo M, Ostrer H, Abraham C, Abreu MT, Atzmon G, Barzilai N, Brant SR, Bressman S, Burns ER, Chowers Y, Clark LN, Darvasi A, Doheny D, Duerr RH, Eliakim R, Giladi N, Gregersen PK, Hakonarson H, Jones MR, Marder K, McGovern DP, Mulle J, Orr-Urtreger A, Proctor DD, Pulver A, Rotter JI, Silverberg MS, Ullman T, Warren ST, Waterman M, Zhang W, Bergman A, Mayer L, Katz S, Desnick RJ, Cho JH, Peter I. A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet. 2012; 8(3):e1002559.
      View in: PubMed
    19. Long MD, Kappelman MD, Martin CF, Lewis JD, Mayer L, Kinneer PM, Sandler RS. Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis. 2012 Nov; 18(11):2099-106.
      View in: PubMed
    20. Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M, Gavrilova O, Orandle M, Mayer L, Macpherson AJ, McCoy KD, Fraser-Liggett C, Matzinger P. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med. 2011 Dec; 17(12):1585-93.
      View in: PubMed
    21. Dunkin D, Berin MC, Mayer L. Allergic sensitization can be induced via multiple physiologic routes in an adjuvant-dependent manner. J Allergy Clin Immunol. 2011 Dec; 128(6):1251-1258.e2.
      View in: PubMed
    22. Peter I, Mitchell AA, Ozelius L, Erazo M, Hu J, Doheny D, Abreu MT, Present DH, Ullman T, Benkov K, Korelitz BI, Mayer L, Desnick RJ. Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study. BMC Med Genet. 2011; 12:63.
      View in: PubMed
    23. Kavanaugh AF, Mayer LF, Cush JJ, Hanauer SB. Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease. Am J Med. 2011 Apr; 124(4 Suppl):e1-18.
      View in: PubMed
    24. Dotan I, Werner L, Vigodman S, Agarwal S, Pfeffer J, Horowitz N, Malter L, Abreu M, Ullman T, Guzner-Gur H, Halpern Z, Mayer L. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflamm Bowel Dis. 2012 Feb; 18(2):261-8.
      View in: PubMed
    25. Ouyang X, Zhang R, Yang J, Li Q, Qin L, Zhu C, Liu J, Ning H, Shin MS, Gupta M, Qi CF, He JC, Lira SA, Morse HC, Ozato K, Mayer L, Xiong H. Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun. 2011; 2:314.
      View in: PubMed
    26. Murphy SJ, Mayer L, Abreu MT. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis. J Clin Gastroenterol. 2011 Jan; 45(1):83-4.
      View in: PubMed
    27. Agarwal S, Smereka P, Harpaz N, Cunningham-Rundles C, Mayer L. Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease. Inflamm Bowel Dis. 2011 Jan; 17(1):251-9.
      View in: PubMed
    28. Hovhannisyan Z, Treatman J, Littman DR, Mayer L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology. 2011 Mar; 140(3):957-65.
      View in: PubMed
    29. Fukata M, Shang L, Santaolalla R, Sotolongo J, Pastorini C, España C, Ungaro R, Harpaz N, Cooper HS, Elson G, Kosco-Vilbois M, Zaias J, Perez MT, Mayer L, Vamadevan AS, Lira SA, Abreu MT. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis. 2011 Jul; 17(7):1464-73.
      View in: PubMed
    30. Dahan S, Rabinowitz KM, Martin AP, Berin MC, Unkeless JC, Mayer L. Notch-1 signaling regulates intestinal epithelial barrier function, through interaction with CD4+ T cells, in mice and humans. Gastroenterology. 2011 Feb; 140(2):550-9.
      View in: PubMed
    31. Sandborn WJ, Colombel JF, Frankel M, Hommes D, Lowder JN, Mayer L, Plevy S, Stokkers P, Travis S, Van Assche G, Baumgart DC, Targan SR. Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis. Gut. 2010 Nov; 59(11):1485-92.
      View in: PubMed
    32. Yu JE, De Ravin SS, Uzel G, Landers C, Targan S, Malech HL, Holland SM, Cao W, Harpaz N, Mayer L, Cunningham-Rundles C. High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin Immunol. 2011 Jan; 138(1):14-22.
      View in: PubMed
    33. Bongers G, Maussang D, Muniz LR, Noriega VM, Fraile-Ramos A, Barker N, Marchesi F, Thirunarayanan N, Vischer HF, Qin L, Mayer L, Harpaz N, Leurs R, Furtado GC, Clevers H, Tortorella D, Smit MJ, Lira SA. The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice. J Clin Invest. 2010 Nov; 120(11):3969-78.
      View in: PubMed
    34. Shah B, Mayer L. Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease. Expert Rev Clin Immunol. 2010 Jul; 6(4):607-20.
      View in: PubMed
    35. Roda G, Caponi A, Benevento M, Nanni P, Mezzanotte L, Belluzzi A, Mayer L, Roda A. New proteomic approaches for biomarker discovery in inflammatory bowel disease. Inflamm Bowel Dis. 2010 Jul; 16(7):1239-46.
      View in: PubMed
    36. Blázquez AB, Mayer L, Berin MC. Thymic stromal lymphopoietin is required for gastrointestinal allergy but not oral tolerance. Gastroenterology. 2010 Oct; 139(4):1301-9.
      View in: PubMed
    37. Sicherer SH, Wood RA, Stablein D, Burks AW, Liu AH, Jones SM, Fleischer DM, Leung DY, Grishin A, Mayer L, Shreffler W, Lindblad R, Sampson HA. Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy. J Allergy Clin Immunol. 2010 May; 125(5):1077-1083.e8.
      View in: PubMed
    38. Baumgart DC, Targan SR, Dignass AU, Mayer L, van Assche G, Hommes DW, Hanauer SB, Mahadevan U, Reinisch W, Plevy SE, Salzberg BA, Buchman AL, Mechkov GM, Krastev ZA, Lowder JN, Frankel MB, Sandborn WJ. Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis. 2010 Apr; 16(4):620-9.
      View in: PubMed
    39. Agarwal S, Mayer L. Gastrointestinal manifestations in primary immune disorders. Inflamm Bowel Dis. 2010 Apr; 16(4):703-11.
      View in: PubMed
    40. Mayer L. Evolving paradigms in the pathogenesis of IBD. J Gastroenterol. 2010; 45(1):9-16.
      View in: PubMed
    41. Nguyen HT, Dalmasso G, Yan Y, Laroui H, Dahan S, Mayer L, Sitaraman SV, Merlin D. MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. J Biol Chem. 2010 Jan 8; 285(2):1479-89.
      View in: PubMed
    42. Blázquez AB, Knight AK, Getachew H, Bromberg JS, Lira SA, Mayer L, Berin MC. A functional role for CCR6 on proallergic T cells in the gastrointestinal tract. Gastroenterology. 2010 Jan; 138(1):275-84.e1-4.
      View in: PubMed
    43. Agarwal S, Mayer L. Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes. J Allergy Clin Immunol. 2009 Oct; 124(4):658-64.
      View in: PubMed
    44. Roda G, Dahan S, Mezzanotte L, Caponi A, Roth-Walter F, Pinn D, Mayer L. Defect in CEACAM family member expression in Crohn's disease IECs is regulated by the transcription factor SOX9. Inflamm Bowel Dis. 2009 Dec; 15(12):1775-83.
      View in: PubMed
    45. Liu W, Ouyang X, Yang J, Liu J, Li Q, Gu Y, Fukata M, Lin T, He JC, Abreu M, Unkeless JC, Mayer L, Xiong H. AP-1 activated by toll-like receptors regulates expression of IL-23 p19. J Biol Chem. 2009 Sep 4; 284(36):24006-16.
      View in: PubMed
    46. Podgrabinska S, Kamalu O, Mayer L, Shimaoka M, Snoeck H, Randolph GJ, Skobe M. Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism. J Immunol. 2009 Aug 1; 183(3):1767-79.
      View in: PubMed
    47. Shang L, Thirunarayanan N, Viejo-Borbolla A, Martin AP, Bogunovic M, Marchesi F, Unkeless JC, Ho Y, Furtado GC, Alcami A, Merad M, Mayer L, Lira SA. Expression of the chemokine binding protein M3 promotes marked changes in the accumulation of specific leukocytes subsets within the intestine. Gastroenterology. 2009 Sep; 137(3):1006-18, 1018.e1-3.
      View in: PubMed
    48. Abreu MT, von Tirpitz C, Hardi R, Kaatz M, Van Assche G, Rutgeerts P, Bisaccia E, Goerdt S, Hanauer S, Knobler R, Mannon P, Mayer L, Ochsenkuhn T, Sandborn WJ, Parenti D, Lee K, Reinisch W. Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study. Inflamm Bowel Dis. 2009 Jun; 15(6):829-36.
      View in: PubMed
    49. Dahan S, Roth-Walter F, Martin AP, Arnaboldi P, Mayer L. Lymphoepithelial interactions: a new paradigm. Ann N Y Acad Sci. 2009 May; 1165:323-6.
      View in: PubMed
    50. Ungaro R, Fukata M, Hsu D, Hernandez Y, Breglio K, Chen A, Xu R, Sotolongo J, Espana C, Zaias J, Elson G, Mayer L, Kosco-Vilbois M, Abreu MT. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol. 2009 Jun; 296(6):G1167-79.
      View in: PubMed
    51. Thomas S, Mayer L, Sperber K. Mitochondria influence Fas expression in gp120-induced apoptosis of neuronal cells. Int J Neurosci. 2009; 119(2):157-65.
      View in: PubMed
    52. Marion JF, Waye JD, Present DH, Israel Y, Bodian C, Harpaz N, Chapman M, Itzkowitz S, Steinlauf AF, Abreu MT, Ullman TA, Aisenberg J, Mayer L. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol. 2008 Sep; 103(9):2342-9.
      View in: PubMed
    53. Gu Y, Yang J, Ouyang X, Liu W, Li H, Yang J, Bromberg J, Chen SH, Mayer L, Unkeless JC, Xiong H. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol. 2008 Jul; 38(7):1807-13.
      View in: PubMed
    54. Mayer L. A long needed re-evaluation of cells that suppress. Clin Immunol. 2008 Jun; 127(3):268-9.
      View in: PubMed
    55. Yang J, Yang M, Htut TM, Ouyang X, Hanidu A, Li X, Sellati R, Jiang H, Zhang S, Li H, Zhao J, Ting AT, Mayer L, Unkeless JC, Labadia ME, Hodge M, Li J, Xiong H. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol. 2008 May; 38(5):1204-14.
      View in: PubMed
    56. Shang L, Fukata M, Thirunarayanan N, Martin AP, Arnaboldi P, Maussang D, Berin C, Unkeless JC, Mayer L, Abreu MT, Lira SA. Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propria. Gastroenterology. 2008 Aug; 135(2):529-38.
      View in: PubMed
    57. Dahan S, Roda G, Pinn D, Roth-Walter F, Kamalu O, Martin AP, Mayer L. Epithelial: lamina propria lymphocyte interactions promote epithelial cell differentiation. Gastroenterology. 2008 Jan; 134(1):192-203.
      View in: PubMed
    58. Knight AK, Blázquez AB, Zhang S, Mayer L, Sampson HA, Berin MC. CD4 T cells activated in the mesenteric lymph node mediate gastrointestinal food allergy in mice. Am J Physiol Gastrointest Liver Physiol. 2007 Dec; 293(6):G1234-43.
      View in: PubMed
    59. Li H, Chehade M, Liu W, Xiong H, Mayer L, Berin MC. Allergen-IgE complexes trigger CD23-dependent CCL20 release from human intestinal epithelial cells. Gastroenterology. 2007 Dec; 133(6):1905-15.
      View in: PubMed
    60. Plevy S, Salzberg B, Van Assche G, Regueiro M, Hommes D, Sandborn W, Hanauer S, Targan S, Mayer L, Mahadevan U, Frankel M, Lowder J. A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology. 2007 Nov; 133(5):1414-22.
      View in: PubMed
    61. Clark M, Colombel JF, Feagan BC, Fedorak RN, Hanauer SB, Kamm MA, Mayer L, Regueiro C, Rutgeerts P, Sandborn WJ, Sands BE, Schreiber S, Targan S, Travis S, Vermeire S. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology. 2007 Jul; 133(1):312-39.
      View in: PubMed
    62. Brown SJ, Mayer L. The immune response in inflammatory bowel disease. Am J Gastroenterol. 2007 Sep; 102(9):2058-69.
      View in: PubMed
    63. Sartor RB, Blumberg RS, Braun J, Elson CO, Mayer LF. CCFA microbial-host interactions workshop: highlights and key observations. Inflamm Bowel Dis. 2007 May; 13(5):600-19.
      View in: PubMed
    64. Huang B, Zhao J, Shen S, Li H, He KL, Shen GX, Mayer L, Unkeless J, Li D, Yuan Y, Zhang GM, Xiong H, Feng ZH. Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res. 2007 May 1; 67(9):4346-52.
      View in: PubMed
    65. Keshavarzian A, Mayer L, Salzberg B, Garone M, Finkelstein W, Cappa J, Brand M, Hain J, Zelinger D, Hegedus R, Diamond RH, Campbell U, Lane C, Stang P, Watson J, Cominelli F. A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency. Gastroenterol Hepatol (N Y). 2007 May; 3(5):381-90.
      View in: PubMed
    66. Bogunovic M, Davé SH, Tilstra JS, Chang DT, Harpaz N, Xiong H, Mayer LF, Plevy SE. Enteroendocrine cells express functional Toll-like receptors. Am J Physiol Gastrointest Liver Physiol. 2007 Jun; 292(6):G1770-83.
      View in: PubMed
    67. Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, Dulphy N, Caillat-Zucman S, Paul P, Gornet JM, Douay C, Ravet S, Tamouza R, Charron D, Lémann M, Mayer L, Toubert A. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology. 2007 Jun; 132(7):2346-58.
      View in: PubMed
    68. Dotan I, Allez M, Nakazawa A, Brimnes J, Schulder-Katz M, Mayer L. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol. 2007 Jun; 292(6):G1630-40.
      View in: PubMed
    69. Perera L, Shao L, Patel A, Evans K, Meresse B, Blumberg R, Geraghty D, Groh V, Spies T, Jabri B, Mayer L. Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm Bowel Dis. 2007 Mar; 13(3):298-307.
      View in: PubMed
    70. Dahan S, Roth-Walter F, Arnaboldi P, Agarwal S, Mayer L. Epithelia: lymphocyte interactions in the gut. Immunol Rev. 2007 Feb; 215:243-53.
      View in: PubMed
    71. Nanni P, Parisi D, Roda G, Casale M, Belluzzi A, Roda E, Mayer L, Roda A. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis. Rapid Commun Mass Spectrom. 2007; 21(24):4142-8.
      View in: PubMed
    72. Mayer L, Young Y. Infusion reactions and their management. Gastroenterol Clin North Am. 2006 Dec; 35(4):857-66.
      View in: PubMed
    73. Knight AK, Mayer L, Franks AG, Cunningham-Rundles C. Hypogammaglobulinemia with facial edema. PLoS Med. 2006 Dec; 3(12):e475.
      View in: PubMed
    74. Kucharzik T, Maaser C, Lügering A, Kagnoff M, Mayer L, Targan S, Domschke W. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis. 2006 Nov; 12(11):1068-83.
      View in: PubMed
    75. Shao L, Allez M, Park MS, Mayer L. Immunomodulatory roles of the carcinoembryonic antigen family of glycoproteins. Ann N Y Acad Sci. 2006 Aug; 1072:194-209.
      View in: PubMed
    76. Mayer L. When is too much enough? Gastroenterology. 2006 Apr; 130(4):1352-4.
      View in: PubMed
    77. Zhao J, Kong HJ, Li H, Huang B, Yang M, Zhu C, Bogunovic M, Zheng F, Mayer L, Ozato K, Unkeless J, Xiong H. IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J Biol Chem. 2006 Apr 14; 281(15):10073-80.
      View in: PubMed
    78. Kraus TA, Cheifetz A, Toy L, Meddings JB, Mayer L. Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease. Inflamm Bowel Dis. 2006 Feb; 12(2):82-8; discussion 81.
      View in: PubMed
    79. Mayer L. Living with rejection--lessons for us all. Gastroenterology. 2006 Feb; 130(2):294.
      View in: PubMed
    80. Ko J, Mayer L. Oral tolerance: lessons on treatment of food allergy. Eur J Gastroenterol Hepatol. 2005 Dec; 17(12):1299-303.
      View in: PubMed
    81. Kraus TA, Mayer L. Oral tolerance and inflammatory bowel disease. Curr Opin Gastroenterol. 2005 Nov; 21(6):692-6.
      View in: PubMed
    82. Safadi R, Alvarez CE, Ohta M, Brimnes J, Kraus T, Mehal W, Bromberg J, Mayer L, Friedman SL. Enhanced oral tolerance in transgenic mice with hepatocyte secretion of IL-10. J Immunol. 2005 Sep 15; 175(6):3577-83.
      View in: PubMed
    83. Ponda PP, Mayer L. Mucosal epithelium in health and disease. Curr Mol Med. 2005 Sep; 5(6):549-56.
      View in: PubMed
    84. Mayer L. Mucosal immunity. Immunol Rev. 2005 Aug; 206:5.
      View in: PubMed
    85. Shao L, Kamalu O, Mayer L. Non-classical MHC class I molecules on intestinal epithelial cells: mediators of mucosal crosstalk. Immunol Rev. 2005 Aug; 206:160-76.
      View in: PubMed
    86. Kraus TA, Brimnes J, Muong C, Liu JH, Moran TM, Tappenden KA, Boros P, Mayer L. Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops. J Clin Invest. 2005 Aug; 115(8):2234-43.
      View in: PubMed
    87. Cheifetz A, Mayer L. Monoclonal antibodies, immunogenicity, and associated infusion reactions. Mt Sinai J Med. 2005 Jul; 72(4):250-6.
      View in: PubMed
    88. Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC, Xiong H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 2005 Jun 15; 65(12):5009-14.
      View in: PubMed
    89. Shao L, Jacobs AR, Johnson VV, Mayer L. Activation of CD8+ regulatory T cells by human placental trophoblasts. J Immunol. 2005 Jun 15; 174(12):7539-47.
      View in: PubMed
    90. Wang J, Mayer L, Cunningham-Rundles C. Use of GM-CSF in the treatment of colitis associated with chronic granulomatous disease. J Allergy Clin Immunol. 2005 May; 115(5):1092-4.
      View in: PubMed
    91. Brimnes J, Allez M, Dotan I, Shao L, Nakazawa A, Mayer L. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol. 2005 May 1; 174(9):5814-22.
      View in: PubMed
    92. Xiong H, Li H, Kong HJ, Chen Y, Zhao J, Xiong S, Huang B, Gu H, Mayer L, Ozato K, Unkeless JC. Ubiquitin-dependent degradation of interferon regulatory factor-8 mediated by Cbl down-regulates interleukin-12 expression. J Biol Chem. 2005 Jun 24; 280(25):23531-9.
      View in: PubMed
    93. Mayer L. A novel approach to the treatment of ulcerative colitis: is it kosher? Gastroenterology. 2005 Apr; 128(4):1117-9.
      View in: PubMed
    94. Genden EM, Govindaraj S, Chaboki H, Cleven H, Fedorova E, Bromberg JS, Mayer L. Reepithelialization of orthotopic tracheal allografts prevents rejection after withdrawal of immunosuppression. Ann Otol Rhinol Laryngol. 2005 Apr; 114(4):279-88.
      View in: PubMed
    95. Chehade M, Mayer L. Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol. 2005 Jan; 115(1):3-12; quiz 13.
      View in: PubMed
    96. Kaser A, Nieuwenhuis EE, Strober W, Mayer L, Fuss I, Colgan S, Blumberg RS. Natural killer T cells in mucosal homeostasis. Ann N Y Acad Sci. 2004 Dec; 1029:154-68.
      View in: PubMed
    97. Allez M, Brimnes J, Shao L, Dotan I, Nakazawa A, Mayer L. Activation of a unique population of CD8(+) T cells by intestinal epithelial cells. Ann N Y Acad Sci. 2004 Dec; 1029:22-35.
      View in: PubMed
    98. Kraus TA, Toy L, Chan L, Childs J, Cheifetz A, Mayer L. Failure to induce oral tolerance in Crohn's and ulcerative colitis patients: possible genetic risk. Ann N Y Acad Sci. 2004 Dec; 1029:225-38.
      View in: PubMed
    99. Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, Dolin B, Goodman N, Groden C, Hornung RL, Quezado M, Yang Z, Neurath MF, Salfeld J, Veldman GM, Schwertschlag U, Strober W. Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med. 2004 Nov 11; 351(20):2069-79.
      View in: PubMed
    100. Shao L, Mayer L. Treatment of disease through oral tolerance. Discov Med. 2004 Oct; 4(23):338-43.
      View in: PubMed
    101. Allez M, Mayer L. Regulatory T cells: peace keepers in the gut. Inflamm Bowel Dis. 2004 Sep; 10(5):666-76.
      View in: PubMed
    102. Hanauer SB, Wagner CL, Bala M, Mayer L, Travers S, Diamond RH, Olson A, Bao W, Rutgeerts P. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease. Clin Gastroenterol Hepatol. 2004 Jul; 2(7):542-53.
      View in: PubMed
    103. Kraus TA, Toy L, Chan L, Childs J, Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology. 2004 Jun; 126(7):1771-8.
      View in: PubMed
    104. Mayer L, Shao L. The use of oral tolerance in the therapy of chronic inflammatory/autoimmune diseases. J Pediatr Gastroenterol Nutr. 2004 Jun; 39 Suppl 3:S746-7.
      View in: PubMed
    105. Mayer L, Shao L. Therapeutic potential of oral tolerance. Nat Rev Immunol. 2004 Jun; 4(6):407-19.
      View in: PubMed
    106. Nakazawa A, Dotan I, Brimnes J, Allez M, Shao L, Tsushima F, Azuma M, Mayer L. The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells. Gastroenterology. 2004 May; 126(5):1347-57.
      View in: PubMed
    107. Tukel T, Shalata A, Present D, Rachmilewitz D, Mayer L, Grant D, Risch N, Desnick RJ. Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families. Am J Hum Genet. 2004 Apr; 74(4):623-36.
      View in: PubMed
    108. Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Hanauer SB. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology. 2004 Feb; 126(2):402-13.
      View in: PubMed
    109. Mayer L. Redefining autoimmunity. Gastroenterology. 2003 Dec; 125(6):1574.
      View in: PubMed
    110. Colgan SP, Pitman RS, Nagaishi T, Mizoguchi A, Mizoguchi E, Mayer LF, Shao L, Sartor RB, Subjeck JR, Blumberg RS. Intestinal heat shock protein 110 regulates expression of CD1d on intestinal epithelial cells. J Clin Invest. 2003 Sep; 112(5):745-54.
      View in: PubMed
    111. Sandborn WJ, Present DH, Isaacs KL, Wolf DC, Greenberg E, Hanauer SB, Feagan BG, Mayer L, Johnson T, Galanko J, Martin C, Sandler RS. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology. 2003 Aug; 125(2):380-8.
      View in: PubMed
    112. Cheifetz A, Smedley M, Martin S, Reiter M, Leone G, Mayer L, Plevy S. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol. 2003 Jun; 98(6):1315-24.
      View in: PubMed
    113. Genden EM, Iskander A, Bromberg JS, Mayer L. The kinetics and pattern of tracheal allograft re-epithelialization. Am J Respir Cell Mol Biol. 2003 Jun; 28(6):673-81.
      View in: PubMed
    114. Mayer L. Mucosal immunity. Pediatrics. 2003 Jun; 111(6 Pt 3):1595-600.
      View in: PubMed
    115. van de Wal Y, Corazza N, Allez M, Mayer LF, Iijima H, Ryan M, Cornwall S, Kaiserlian D, Hershberg R, Koezuka Y, Colgan SP, Blumberg RS. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells. Gastroenterology. 2003 May; 124(5):1420-31.
      View in: PubMed
    116. Plevy S, Mayer L. Meeting summary: Signal transduction pathways in immune and inflammatory cells. November 30-December 3, 2000, Amelia Island, Florida, U.S.A. Inflamm Bowel Dis. 2003 Jan; 9(1):28-33.
      View in: PubMed
    117. Genden EM, Iskander AJ, Bromberg JS, Mayer L. Orthotopic tracheal allografts undergo reepithelialization with recipient-derived epithelium. Arch Otolaryngol Head Neck Surg. 2003 Jan; 129(1):118-23.
      View in: PubMed
    118. Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut. 2002 Dec; 51(6):818-26.
      View in: PubMed
    119. Xiong H, Zhu C, Li H, Chen F, Mayer L, Ozato K, Unkeless JC, Plevy SE. Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J Biol Chem. 2003 Jan 24; 278(4):2271-7.
      View in: PubMed
    120. Allez M, Brimnes J, Dotan I, Mayer L. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology. 2002 Nov; 123(5):1516-26.
      View in: PubMed
    121. Mayer L. The real meaning of translational research. Gastroenterology. 2002 Sep; 123(3):665.
      View in: PubMed
    122. Dotan I, Mayer L. Immunopathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol. 2002 Jul; 18(4):421-7.
      View in: PubMed
    123. Genden EM, Boros P, Liu J, Bromberg JS, Mayer L. Orthotopic tracheal transplantation in the murine model. Transplantation. 2002 May 15; 73(9):1420-5.
      View in: PubMed
    124. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002 May 4; 359(9317):1541-9.
      View in: PubMed
    125. Allen C, Dos Santos N, Gallagher R, Chiu GN, Shu Y, Li WM, Johnstone SA, Janoff AS, Mayer LD, Webb MS, Bally MB. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci Rep. 2002 Apr; 22(2):225-50.
      View in: PubMed
    126. Denyssevych T, Lestou VS, Knesevich S, Robichaud M, Salski C, Tan R, Gascoyne RD, Horsman DE, Mayer LD. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1. Leukemia. 2002 Feb; 16(2):276-83.
      View in: PubMed
    127. Li WM, Xue L, Mayer LD, Bally MB. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes. Biochim Biophys Acta. 2001 Aug 6; 1513(2):193-206.
      View in: PubMed
    128. Sacchi CT, Lemos AP, Popovic T, De Morais JC, Whitney AM, Melles CE, Brondi LM, Monteiro LM, Paiva MV, Solari CA, Mayer LW. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development. J Clin Microbiol. 2001 Aug; 39(8):2897-903.
      View in: PubMed
    129. Waterhouse DN, Tardi PG, Mayer LD, Bally MB. A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles. Drug Saf. 2001; 24(12):903-20.
      View in: PubMed
    130. Zhang L, Scott MG, Yan H, Mayer LD, Hancock RE. Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry. 2000 Nov 28; 39(47):14504-14.
      View in: PubMed
    131. Tondella ML, Popovic T, Rosenstein NE, Lake DB, Carlone GM, Mayer LW, Perkins BA. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team. J Clin Microbiol. 2000 Sep; 38(9):3323-8.
      View in: PubMed
    132. Dragowska WH, Lopes de Menezes DE, Sartor J, Mayer LD. Quantitative fluorescence cytometric analysis of Bcl-2 levels in tumor cells exhibiting a wide range of inherent Bcl-2 protein expression: correlation with Western blot analysis. Cytometry. 2000 Aug 1; 40(4):346-52.
      View in: PubMed
    133. Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES, Mayer LD. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Res. 2000 Jun 1; 60(11):2964-72.
      View in: PubMed
    134. Johnstone SA, Gelmon K, Mayer LD, Hancock RE, Bally MB. In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines. Anticancer Drug Des. 2000 Apr; 15(2):151-60.
      View in: PubMed
    135. Hershberg RM, Mayer LF. Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol Today. 2000 Mar; 21(3):123-8.
      View in: PubMed
    136. Gelmon KA, Tolcher A, Diab AR, Bally MB, Embree L, Hudon N, Dedhar C, Ayers D, Eisen A, Melosky B, Burge C, Logan P, Mayer LD. Phase I study of liposomal vincristine. J Clin Oncol. 1999 Feb; 17(2):697-705.
      View in: PubMed
    137. Sacchi CT, Lemos AP, Whitney AM, Solari CA, Brandt ME, Melles CE, Frasch CE, Mayer LW. Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system. Clin Diagn Lab Immunol. 1998 May; 5(3):348-54.
      View in: PubMed
    138. Embree L, Gelmon K, Tolcher A, Hudon N, Heggie J, Dedhar C, Logan P, Bally MB, Mayer LD. Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection. Cancer Chemother Pharmacol. 1998; 41(5):347-52.
      View in: PubMed
    139. Krishna R, Mayer LD. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors. Cancer Res. 1997 Dec 1; 57(23):5246-53.
      View in: PubMed
    140. Embree L, Gelmon KA, Tolcher AW, Hudon NJ, Heggie JR, Dedhar C, Webb MS, Bally MB, Mayer LD. Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injection. J Pharm Biomed Anal. 1997 Dec; 16(4):675-87.
      View in: PubMed
    141. Mayer LD, Dougherty G, Harasym TO, Bally MB. The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors. J Pharmacol Exp Ther. 1997 Mar; 280(3):1406-14.
      View in: PubMed
    142. Peters VB, Mayer LF, Sperber KE. Correlation of in vitro T-cell and B-cell function with responses to childhood vaccines in children with human immunodeficiency virus infection. Viral Immunol. 1997; 10(4):197-206.
      View in: PubMed
    143. Brandt ME, Pfaller MA, Hajjeh RA, Graviss EA, Rees J, Spitzer ED, Pinner RW, Mayer LW. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance Group. J Infect Dis. 1996 Oct; 174(4):812-20.
      View in: PubMed
    144. Weiner HL, Mayer LF. Oral tolerance: mechanisms and applications. Introduction. Ann N Y Acad Sci. 1996 Feb 13; 778:xiii-xviii.
      View in: PubMed
    145. Johnson BJ, Sviat SL, Happ CM, Dunn JJ, Frantz JC, Mayer LW, Piesman J. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2. Vaccine. 1995 Aug; 13(12):1086-94.
      View in: PubMed
    146. Boman NL, Masin D, Mayer LD, Cullis PR, Bally MB. Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors. Cancer Res. 1994 Jun 1; 54(11):2830-3.
      View in: PubMed
    147. Bally MB, Masin D, Nayar R, Cullis PR, Mayer LD. Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice. Cancer Chemother Pharmacol. 1994; 34(2):137-46.
      View in: PubMed
    148. Lewis JA, Chang GJ, Lanciotti RS, Kinney RM, Mayer LW, Trent DW. Phylogenetic relationships of dengue-2 viruses. Virology. 1993 Nov; 197(1):216-24.
      View in: PubMed
    149. Golde WT, Burkot TR, Sviat S, Keen MG, Mayer LW, Johnson BJ, Piesman J. The major histocompatibility complex-restricted response of recombinant inbred strains of mice to natural tick transmission of Borrelia burgdorferi. J Exp Med. 1993 Jan 1; 177(1):9-17.
      View in: PubMed
    150. Johnson BJ, Happ CM, Mayer LW, Piesman J. Detection of Borrelia burgdorferi in ticks by species-specific amplification of the flagellin gene. Am J Trop Med Hyg. 1992 Dec; 47(6):730-41.
      View in: PubMed
    151. Posnett DN, Schmelkin I, Burton DA, August A, McGrath H, Mayer LF. T cell antigen receptor V gene usage. Increases in V beta 8+ T cells in Crohn's disease. J Clin Invest. 1990 Jun; 85(6):1770-6.
      View in: PubMed
    152. Bally MB, Nayar R, Masin D, Hope MJ, Cullis PR, Mayer LD. Liposomes with entrapped doxorubicin exhibit extended blood residence times. Biochim Biophys Acta. 1990 Mar 30; 1023(1):133-9.
      View in: PubMed
    153. Madden TD, Harrigan PR, Tai LC, Bally MB, Mayer LD, Redelmeier TE, Loughrey HC, Tilcock CP, Reinish LW, Cullis PR. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem Phys Lipids. 1990 Mar; 53(1):37-46.
      View in: PubMed
    154. Mayer LD, Bally MB, Loughrey H, Masin D, Cullis PR. Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors. Cancer Res. 1990 Feb 1; 50(3):575-9.
      View in: PubMed
    155. Bally MB, Nayar R, Masin D, Cullis PR, Mayer LD. Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes. Cancer Chemother Pharmacol. 1990; 27(1):13-9.
      View in: PubMed
    156. Mayer LD, Tai LC, Ko DS, Masin D, Ginsberg RS, Cullis PR, Bally MB. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 1989 Nov 1; 49(21):5922-30.
      View in: PubMed
    157. Levine B, Leiderman I, Siegal FP, Mayer LF, Cunningham-Rundles C. Genotypes of the group-specific component protein in black intravenous drug abusers. J Infect Dis. 1989 Jan; 159(1):147-8.
      View in: PubMed
    158. Balazsovits JA, Mayer LD, Bally MB, Cullis PR, McDonell M, Ginsberg RS, Falk RE. Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin. Cancer Chemother Pharmacol. 1989; 23(2):81-6.
      View in: PubMed
    159. Nano FE, Barstad PA, Mayer LW, Coligan JE, Caldwell HD. Partial amino acid sequence and molecular cloning of the encoding gene for the major outer membrane protein of Chlamydia trachomatis. Infect Immun. 1985 May; 48(2):372-7.
      View in: PubMed
    160. Howe TR, Mayer LW, Barbour AG. A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete. Science. 1985 Feb 8; 227(4687):645-6.
      View in: PubMed
    161. Mayer LD, Bally MB, Hope MJ, Cullis PR. Uptake of dibucaine into large unilamellar vesicles in response to a membrane potential. J Biol Chem. 1985 Jan 25; 260(2):802-8.
      View in: PubMed
    162. Posnett DN, Bigler RD, Bushkin Y, Fisher DE, Wang CY, Mayer LF, Chiorazzi N, Kunkel HG. T cell antiidiotypic antibodies reveal differences between two human leukemias. J Exp Med. 1984 Aug 1; 160(2):494-505.
      View in: PubMed
    163. Mayer LF, Thompson C, Fu SM, Kunkel HG. T cell factors regulating B cell activation and differentiation. Curr Top Microbiol Immunol. 1984; 113:77-85.
      View in: PubMed
    164. Swanson J, Mayer LW, Tam MR. Antigenicity of Neisseria gonorrhoeae outer membrane protein(s) III detected by immunoprecipitation and Western blot transfer with a monoclonal antibody. Infect Immun. 1982 Nov; 38(2):668-72.
      View in: PubMed
    165. Goodman DH, Wert AD, Anand SC, Cowan MN, Mayer LD. Cromolyn sodium in the treatment of grass pollen asthma. Ann Allergy. 1972 May; 30(5):258-61.
      View in: PubMed
    166. COHEN SG, MAYER LD, CRIEP LH. The experimental production of arteritis by passive sensitization. J Immunol. 1951 May; 66(5):487-96.
      View in: PubMed
    167. MAYER LD, CRIEP LH. Tetany from small bowel resection and small and large bowel exclusion. Gastroenterology. 1949 Dec; 13(6):597-602, illust.
      View in: PubMed
    Mayer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067